Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BTSG
stocks logo

BTSG

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
2.97B
+8.94%
0.175
+74.82%
3.15B
+8.34%
0.212
+92.65%
3.30B
+7.96%
0.266
+20.9%
Estimates Revision
The market is revising Upward the revenue expectations for BrightSpring Health Services, Inc. (BTSG) for FY2025, with the revenue forecasts being adjusted by 2.65% over the past three months. During the same period, the stock price has changed by 27.31%.
Revenue Estimates for FY2025
Revise Upward
up Image
+2.65%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+48.59%
In Past 3 Month
Stock Price
Go Up
up Image
+27.31%
In Past 3 Month
6 Analyst Rating
up Image0
Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is 29.04 USD with a low forecast of 25.00 USD and a high forecast of 37.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
up Image0
Current: 22.000
sliders
Low
25.00
Averages
29.04
High
37.00
up Image0
Current: 22.000
sliders
Low
25.00
Averages
29.04
High
37.00
TD Cowen
NULL -> Buy
initiated
$37
2025-06-23
Reason
TD Cowen
Price Target
$37
2025-06-23
initiated
NULL -> Buy
Reason
TD Cowen initiated coverage of BrightSpring Health with a Buy rating and $37 price target. The company, a leading oncology-focused specialty pharmacy and home health provider, is positioned to benefit from continued specialty growth and a generic wave driven by pharma's upcoming patent cliff, the analyst tells investors in a research note. The firm says its price target implies the shares trade at 15-times its adjusted EBITDA estimate for fiscal 2026.
BTIG
David Larsen
Buy
maintain
$25 -> $30
2025-05-29
Reason
BTIG
David Larsen
Price Target
$25 -> $30
2025-05-29
maintain
Buy
Reason
BTIG analyst David Larsen raised the firm's price target on BrightSpring Health to $30 from $25 and keeps a Buy rating on the shares as part of a broader research note in summary of presentations at the recent Boston Digital Health Summit. The firm is citing the fairly high drug price inflation rates, especially amongst specialty and oncology medications, as well as good volumes, especially in the post-acute environment in boosting its price target on BrightSpring.
Wells Fargo
Stephen Baxter
Overweight
maintain
$25 -> $27
2025-05-13
Reason
Wells Fargo
Stephen Baxter
Price Target
$25 -> $27
2025-05-13
maintain
Overweight
Reason
Wells Fargo analyst Stephen Baxter raised the firm's price target on BrightSpring Health to $27 from $25 and keeps an Overweight rating on the shares. The firm is updating the model following the Q1 2025 beat and guidance increase. Wells is also increasing Pharmacy estimates and refining Provider estimates.
UBS
A.J. Rice
Strong Buy
Maintains
$22 → $30
2025-01-29
Reason
UBS
A.J. Rice
Price Target
$22 → $30
2025-01-29
Maintains
Strong Buy
Reason
Morgan Stanley
Erin Wright
Buy
Maintains
$19 → $20
2024-12-17
Reason
Morgan Stanley
Erin Wright
Price Target
$19 → $20
2024-12-17
Maintains
Buy
Reason
CJS Securities
Larry Solow
Buy
Initiates
$27
2024-12-12
Reason
CJS Securities
Larry Solow
Price Target
$27
2024-12-12
Initiates
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Brightspring Health Services Inc (BTSG.O) is 24.24, compared to its 5-year average forward P/E of 23.19. For a more detailed relative valuation and DCF analysis to assess Brightspring Health Services Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
23.19
Current PE
24.24
Overvalued PE
30.00
Undervalued PE
16.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average EV/EBITDA
9.69
Current EV/EBITDA
10.97
Overvalued EV/EBITDA
10.85
Undervalued EV/EBITDA
8.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PS
0.23
Current PS
0.31
Overvalued PS
0.29
Undervalued PS
0.17

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders areSelling! The selling amount has increased 162.33% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 162.33% over the last month.
Sold
Bought

BTSG News & Events

Events Timeline

(ET)
2025-07-01
09:52:23
Home health stocks under pressure following proposed rate cuts
select
link
2025-06-11 (ET)
2025-06-11
06:11:40
BrightSpring Health 14M share Spot Secondary priced at $21.75
select
2025-06-10 (ET)
2025-06-10
17:49:53
BrightSpring Health 14M share Spot Secondary; price range $21.50-$22.24
select
Sign Up For More Events
Sign Up For More Events

News

Preview
8.5
07-04NASDAQ.COM
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts

  • Recent Acquisitions by Ensign Group: The Ensign Group, Inc. has acquired two skilled nursing facilities in Idaho and Texas, expanding its portfolio to 348 healthcare operations across 17 states, with a focus on enhancing patient-centered care and addressing gaps in care availability.

  • Financial Growth and Market Position: The company's acquisitions are expected to boost revenue growth, particularly in its Skilled Services segment, which accounted for 97.5% of total revenues in Q1 2025, while shares have increased by 17.8% over the past year, outperforming industry growth.

Preview
7.0
07-02NASDAQ.COM
Centene Pulls 2025 Guidance as Marketplace Growth Falters

  • Centene Corporation Earnings Guidance: Centene Corporation has withdrawn its earnings guidance for 2025 due to unexpected shifts in the health insurance marketplace, anticipating a $1.8 billion shortfall in net risk adjustment revenues, which significantly impacts its profit margins.

  • Market Performance and Future Adjustments: Despite challenges in Medicaid and rising costs, Centene plans to adjust its rates for 2026 to account for higher morbidity, while its Medicare segments are performing better than expected; shares have dropped 43.3% year-to-date compared to a 24.4% decline in the industry.

Preview
5.0
07-01NASDAQ.COM
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment

  • Cigna Group Coverage Announcement: Cigna Group will begin covering RhinAer, a minimally invasive treatment for chronic rhinitis, starting September 15, 2025, providing access to over 15 million members and marking a significant shift in patient care options.

  • Clinical Effectiveness and Market Position: The decision reflects confidence in RhinAer’s clinical efficacy, supported by extensive research, positioning Cigna as a leader in evidence-based, patient-focused healthcare solutions while also enhancing its market value.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Brightspring Health Services Inc (BTSG) stock price today?

The current price of BTSG is 22 USD — it has decreased -0.54 % in the last trading day.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s business?

BrightSpring Health Services, Inc. provides a home and community-based healthcare services platform. The Company is focused on delivering complementary pharmacy and provider services to complex patients. It delivers services through two reportable segments: Pharmacy Solutions and Provider Services. It provides pharmacy services when and where demanded and as required by customers and patients in their homes and communities, often in coordination with its provider services. It delivers a variety of impactful and valuable provider services to high-need, chronic, and complex patients in home and community settings. Its platform offers complimentary pharmacy and provider services that more completely address the multiple needs of complex senior and specialty patients across their various settings and over time. It is also engaged in providing advance care planning, palliative, and hospice services. It provides comprehensive care and clinical solutions in all 50 states.

arrow icon

What is the price predicton of BTSG Stock?

Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is 29.04 USD with a low forecast of 25.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s revenue for the last quarter?

Brightspring Health Services Inc revenue for the last quarter amounts to 2.88B USD, increased 25.92 % YoY.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s earnings per share (EPS) for the last quarter?

Brightspring Health Services Inc. EPS for the last quarter amounts to 0.14 USD, decreased -153.85 % YoY.

arrow icon

What changes have occurred in the market's expectations for Brightspring Health Services Inc (BTSG)'s fundamentals?

The market is revising Upward the revenue expectations for BrightSpring Health Services, Inc. (BTSG) for FY2025, with the revenue forecasts being adjusted by 2.65% over the past three months. During the same period, the stock price has changed by 27.31%.
arrow icon

How many employees does Brightspring Health Services Inc (BTSG). have?

Brightspring Health Services Inc (BTSG) has 37000 emplpoyees as of July 08 2025.

arrow icon

What is Brightspring Health Services Inc (BTSG) market cap?

Today BTSG has the market capitalization of 3.83B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free